^{_{~50–75% respond; ~40–50% achieve remission after typical course. Moderate to large symptom reduction vs. no treatment.}}

^{_{Benefits largely maintained. Relapse rates lower than with meds if therapy was successful (e.g. one study: 16% relapse at 6 mo post-CBT vs 50% after meds).}}

^{_{Still effective: many patients stay well at 1 year. CBT outperforms meds on sustaining gains (effect size g≈0.34 in favor of CBT by 6–12 mo). Some relapse occurs (~30–40% might relapse in year if no further intervention).}}

^{_{Long-term improvement often sustained. In chronic depression, CBT showed lasting symptom relief comparable to psychoanalysis at 5 years. Preventive CBT can cut relapse rates (40% CBT vs 90% control at 6 years in one trial)​pubmed.ncbi.nlm.nih.gov.}}

^{_{Effective acutely and in preventing recurrence. Better long-term profile than meds alone. Sources: Cuijpers et al., 2023; Beutel et al., 2023; Hollon et al., 2005; Teasdale, 2000.}}

_{^{Rapid, high remission: Preliminary data show ~80–87% remission of depression/anxiety in under 10 sessions. Large within-session drops; often >50% symptom reduction in a single session for many. In one series, ~60% achieved full remission within ~4 sessions.}}

_{^{Limited data. If remission is achieved quickly, it’s often stable through 6 months (anecdotally). One naturalistic study (10 sessions over 6 mo) showed continuing improvement with no loss of gains during that period.}}

_{^{No published 12-mo outcomes yet. Expected to be high if initial gains hold. (Burns claims lasting cures; need studies to verify.) Presumably, patients who recovered remain well at 1 year barring new crises.}}

_{^{No data in peer literature yet. Burns asserts low relapse long-term due to addressing root cognitive processes. Ongoing follow-ups are being collected but unpublished.}}

_{^{Extremely fast and high success in short term (often touted ~90%+ recovery rates). Needs independent, long-term research. Sources: Katz & Burns (conf. data); Harrington (dissertation).}}

_{^{~50–60% respond (some symptom improvement) in 4–8 weeks; ~30% achieve remission on first medication. However, drug-placebo differences are small (few-point improvement over placebo on depression scales)​pubmed.ncbi.nlm.nih.gov​pubmed.ncbi.nlm.nih.gov. For anxiety, similar moderate short-term effects.}}

_{^{If medication is continued, remission can persist (maintenance therapy). If medication is stopped after acute phase, ~50% relapse by 6 months is common. Those remaining on meds have a lower relapse (~20–30% by 6 mo)​ox.ac.uk.}}

_{^{With continuous medication, about Maintenance meds vs placebo: relapse ~30–40% vs ~50–60% over a year​ox.ac.uk​psychiatryonline.org. Without medication, relapse can be high (approx. 60–80% within a year for those who responded acutely then stopped). Net: meds need to be maintained for sustained effect.}}

_{^{No long-term cure; often requires ongoing use. Many patients cycling on/off meds have multiple episodes over years. Some remain well on meds, but recurrence is common if meds are discontinued (chronic depression course). No RCTs of 5-year medication vs placebo (unethical to withhold that long), but naturalistic data show high rates of recurrence in 5 years without continuous treatment.}}

_{^{Good for short-term symptom relief in many, but largely palliative. Little evidence of resolving underlying condition – need continuous use for maintenance. Advantage over placebo is modest​pubmed.ncbi.nlm.nih.gov. Sources: Kirsch et al., 2008​pubmed.ncbi.nlm.nih.gov​pubmed.ncbi.nlm.nih.gov; Hollon et al., 2005; Geddes, 2003 (maintenance meta); Mindfulness vs Med meta​ox.ac.uk.}}

_{^{Very rapid, robust response after 1–3 sessions. Psilocybin for major depression: ~70% response within 1–2 weeks, often with scores moving from severe to mild. By 4 weeks, ~67% in remission in one trial (small sample). MDMA for PTSD: ~67–71% no longer meeting PTSD criteria ~1 month after last session​psychiatryonline.org​psychiatryonline.org.}}

_{^{Effects largely sustain at 6 months. Psilocybin trial: depression scores stayed low; ~75% still responding at 6 mo. MDMA for PTSD: some participants improved further by 6 months. No need for ongoing dosing in that period.}}

_{^{12 months:Continued durability shown. Psilocybin study: depression remission ~58% at 12 mo, and 75% with significant improvement. PTSD studies show condition still in remission for most at 12+ months post-MDMA (many maintaining gains). Some patients may relapse after a year, but a sizable portion have enduring relief.}}

_{^{Still under research. Anecdotal/qualitative reports suggest some individuals remain well several years later after psychedelic therapy, especially if integrative therapy continued. Formal 5-year data pending. (Possible need for booster sessions for some.)}}

_{^{Promising one-time/short-term interventions that produce long-lasting change (addressing root psychological issues in many cases). Non-habit-forming (no daily use). Further research will clarify multi-year outcomes. Sources:Gukasyan et al., 2022; Slavich et al., 2022; Mithoefer (MDMA) 2019.}}

_{^{Immediate dramatic improvement reported. One RCT of a similar 6-day program showed ~83% decrease in depression by week 1, vs ~23% in controls. By the end of 6 days + 1 month practice, 100% of depressed participants were in remission(PHQ-9 ≤4). Robbins’ own events often have numerous testimonials of instant breakthroughs (fear elimination, restored hope, etc.).}}

_{^{No independent data at 6 mo. Robbins claims high sustained success. If changes are internalized, many might remain much improved at 6 months. (His team often encourages follow-up coaching which might help maintain momentum.)}}

_{^{12 months:Robbins has claimed ~95% success (people still free of depression/anxiety) at 1 year. This is not verified by peer review. It’s plausible a majority stay better, but exact % unknown. No published study to confirm the 95% figure as of now.}}

_{^{5 years: Claim of ~95% still successful at 5 years, which is extraordinary. No independent verification. Likely some people do relapse or face new challenges, but Robbins asserts that once fundamental patterns are changed, the results persist long-term. Without data, assume some attrition over years but potentially above-average maintenance compared to other methods (due to life changes made).}}

_{^{Extremely high self-reported success but needs independent long-term studies. Not peer-verified beyond short-term. Still, the intensive “pattern change”approach suggests many achieve lasting personal transformations, addressing root psychological patterns in days. Sources: RCT by Slavich et al. (2022); Robbins (personal communications/claims).}}

_{^{Moderate symptom relief. Meta-analysis: effect size ~0.6 for anxiety/depression reduction post-intervention (symptoms notably improved but not always full remission). Often used as augmentation, so immediate result varies.}}

_{^{Generally maintained if practice continues. Those who keep meditating tend to have low symptom levels at 6 mo. For relapse prevention, MBCT roughly halves the risk in high-risk individuals at 6 mo – e.g. one study ~30% relapse MBCT vs ~60% TAU in 6 months (esp. for those with ≥3 prior episodes).}}

_{^{Strong evidence for relapse prevention by 12–14 mo. Pooled data: 38% relapse with MBCT vs 49% with control by 1 year​ox.ac.uk. Comparable to staying on antidepressants (e.g. 44% vs 47% relapse at 2 yrs MBCT vs meds)​[ox.ac.uk](https://www.ox.ac.uk/news/2015-04-21-mindfulness-based-therapy-may-offer-alternative-antidepressants#:~:text=antidepressants www,). If used for acute treatment, some studies show continued symptom improvement or stability at 1 year, especially if mindful habits maintained.}}

_{^{Long-term habit of mindfulness can keep anxiety/depression at bay. No specific 5-yr trial, but likely those who integrate mindfulness have enduring lower vulnerability. (One could stop practicing and lose some benefit, but many incorporate it for life.)}}

_{^{Effective at preventing recurrence (teaches skills to avoid rumination). Requires ongoing practice for maximal benefit, but it’s self-sustaining (no external dependency aside from one’s own commitment). Sources: Hofmann et al., 2010; Piet & Hougaard, 2011 (MBCT meta); Kuyken 2015 (MBCT vs meds)​[ox.ac.uk](https://www.ox.ac.uk/news/2015-04-21-mindfulness-based-therapy-may-offer-alternative-antidepressants#:~:text=antidepressants www,).}}

_{^{Noticeable improvement by 4 months. E.g., ~40–45% remission in depressed patients after a 4-mo exercise program – on par with medication outcomes. Reduces anxiety symptoms acutely via endorphins and calming effect. Many feel mood boost within weeks.}}

_{^{If exercise is continued, mood remains improved. At 6-10 mo follow-ups, those who keep up exercise have significantly lower relapse. One study: at 10 mo, exercise group relapses << medication group (exercise relapse rate ~8% vs meds ~38%, estimated from OR). If exercise stopped, some might relapse by 6 mo (akin to stopping meds).}}

_{^{Regular exercise confers sustained antidepressant effects. A one-year follow-up (SMILE study extension) found people who maintained exercise were still largely depression-free. Exercise becomes a healthy habit preventing return of symptoms. If discontinued, benefits may diminish by 1 year.}}

_{^{Long-term, exercising individuals have lower incidence of depression/anxiety. Some studies suggest lifelong exercise is protective. No specific 5-yr RCT, but epidemiological data: active people have less depression. Someone treating their depression via exercise and sticking with it can essentially keep depression in remission indefinitely.}}

_{^{Acts on physical root causes (brain chemistry, inflammation). Not a one-time cure but a maintenance strategywith broad health benefits. Non-dependent in a harmful way (must keep habit, but that’s positive dependency). Sources: Blumenthal et al., 2007; Babyak et al., 2000 (exercise vs med 10-mo follow-up); Schuch et al., 2016 (exercise meta).}}

_{^{By 3 months, significant improvement possible. In the SMILES trial, 32% remission in diet group vs 8% in control. Depression scores dropped more with healthier diet. Anecdotally, some report better energy and mood within a few weeks of dietary change (especially if correcting deficiencies).}}

_{^{Unknown in rigorous sense – likely if the healthy diet is maintained, the improvement continues. At 6 mo, one might expect those who stuck to the diet remain mostly in remission, whereas those who reverted to poor eating might relapse. (No controlled 6-mo data yet, but physical health improvements from diet often translate to sustained mental health).}}

_{^{No direct data; however, diet improvements generally need to be sustained as a lifestyle. If sustained, potentially ongoing protection against depression. If not, mood may worsen again. (For example, someone feeling good after 3 mo diet might slide back if they return to junk food by 12 mo.)}}

_{^{Not studied over 5 yrs yet. But observational studies show people who eat a consistently healthy diet have lower 5-10 year risk of developing depression. For someone who recovered via diet change, staying on that diet could keep them well long-term and also reduce risk of other illnesses.}}

_{^{Addresses contributing factors (nutrient deficiencies, gut health, inflammation). Safe and holistic. Must be maintained; no dependency on external substances (except continuing good food choices). Sources: Jacka et al., 2017 (SMILES); Lassale, 2018 (diet and depression meta).}}

_{^{After ~8–12 sessions (a few weeks), 60–90% of single-event PTSD patients often no longer have PTSD – i.e., large reduction in anxiety, nightmares, depression related to trauma. For anxiety/depression not from trauma, less data, but some improvement seen after a short course targeting key memories.}}

_{^{For resolved traumas, relief is usually maintained at 6 mo. Many PTSD follow-ups show sustained remission. If EMDR was used for say panic disorder (targeting past panic memories), at 6 mo most patients remain improved as long as no new trauma.}}

_{^{Research in PTSD shows treatment effects persist at 12+ months for the majority (one study found continued improvement at 12 mo post-EMDR without further sessions). For other conditions, likely similar if root memories were processed – benefits persist at 1 year barring other stressors.}}

_{^{Limited specific data, but clinical experience suggests once a traumatic memory is fully processed with EMDR, it tends not to cause return of symptoms even years later. Some complex trauma cases may need additional work over time.}}

_{^{Best for root cause trauma treatment. Essentially curative for many PTSD sufferers (no further therapy or meds needed long-term after processing trauma). Less evidence for primary depression/anxiety, but when those stem from trauma, EMDR can remove the cause and thus alleviate the disorder long-term. Sources: Chen et al., 2014 (meta); van der Kolk, 2019; Lee & Cuijpers, 2013.}}

_{^{Slow initial change. By end of first year, patient may have moderate improvement (some symptom relief, better insight) but often not full remission yet if therapy is ongoing. Not typically “immediate” relief – may even feel worse before better as deep issues are unearthed.}}

_{^{Improvements accumulate. At 6 mo to 1 year post-termination (which could be after several years of therapy), patients often show continuing improvement. Mid-therapy (6mo-1yr in) many get partial relief; the process of understanding and working through is underway.}}

_{^{At 1 year post-therapy, those who completed analysis show significant remission rates. One study found ~40% in full remission and ~70% with marked improvement 2 years after long-term therapy (similar to CBT outcomes)​psychiatryonline.org. If therapy is still ongoing at 12 months, likely moderate progress with more to come.}}

_{^{5+ years: Strong lasting effects. LAC study: patients maintained depression symptom gains 5 years after long-term psychoanalytic therapy. Some evidence suggests effects deepen over time (changes in personality structure lead to resilience). A German 3-year follow-up showed psychoanalytic therapy patients doing better than shorter therapy patients​researchgate.net.}}

_{^{Addresses root psychological causes(past conflicts, relationship patterns). Not quick, but yields deep, enduring change. Low risk of relapse if issues truly resolved (though life can always introduce new challenges). Some risk of dependency if therapy drags on without resolution, but good therapy works toward autonomy. Sources:LAC Depression Study (2023); Leuzinger-Bohleber, 2019; Sandell, 2000 (long-term outcomes).}}